Stock·NYSE·Financial Services
Apollo Global Management Inc. (APO)
- Market cap
- $65.96B
- P/E
- 39.89
- Dividend yield
- 1.92%
- Street target
- $149.00median of 22 analysts
- 52-week range
- $99.56 $153.29
The short version
Where APO stands today, and what CleaRank Financial AI makes of it.
APO at a glance
Apollo Global Management Inc. (APO): Hold, 43/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($125.27 and $124.49).
- Earnings APO beat estimates in 5 of its last 7 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $135.8M and bought $78K over the last 18 months.
- Valuation P/E of 39.9 against 16.5 for the Financial Services sector: a premium to peers (+142%).
Figures as of October 22, 2026.
CleaRank Financial AI
Apollo Global Management Inc. (APO) carries a CleaRank rating of Hold and a model score of 43/100.
The analysts' outlook is the strongest positive, with 16 of 22 analysts rating the stock a buy and a median target 33.4% above the price. The trend is the largest drag: the price is 10.28% below its 200-day average and 10.84% below its 50-day average. Those averages stand at $125.27 for the 50-day and $124.49 for the 200-day. Over the past year, the price has fallen 11.34%.
Only on CleaRank
Figures we compute ourselves from APO's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $111.69 is 10.8% below the 50-day simple moving average of $125.27.Price above its 200-day average ›
The price is 10.3% below the 200-day simple moving average of $124.49.50-day average above the 200-day ›
The 50-day average ($125.27) is 0.6% above the 200-day average ($124.49), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 23% of its 52-week range, between $99.56 and $153.29.
APO share price
Pick a period: each tab shows how far APO has moved over it, to the last close.
Today's trading
Where APO sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 39.89 is 141.8% above the Financial Services median of 16.5.P/S below the sector median ›
The price-to-sales ratio of 1.85 is 51.2% below the sector median of 3.8.Profitable over the last 12 months ›
Net income over the last 12 months was $1.9B on revenue of $35.6B, a net margin of 5.3%.Beat estimates in most recent reports ›
APO beat the EPS estimate in 5 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 1.92%, or $2.15 a share a year.
Key statistics
The headline figures for APO.
As of October 22, 2026, APO trades at $111.69, with a market value of $65.96B, a P/E ratio of 39.89 and a dividend yield of 1.92%.
What the numbers say
CleaRank Financial AI's reading of APO's valuation, growth and risks.
Apollo Global Management Inc. (APO) carries a trailing P/E of 39.89, which is 141.8% above the Financial Services median of 16.5. The peer comparison on this page labels that a premium to peers. On sales, the price-to-sales ratio of 1.85 is 51.3% below the sector median of 3.8. The company's market capitalisation stands at $66.0B.
APO's revenue grew 63.80% in the latest quarter year on year, well ahead of the sector median of 11.7%, so growth clearly outpaces the sector. Its net margin is 5.27% and its operating margin is 21.95%. Return on equity, a measure of what shareholders' capital earns, stands at 11.41%, which is below the sector median of 13.8%. On the balance sheet, debt-to-equity is 1.01, and the trailing dividend yield is 1.92%, equal to $2.15 a share per year.
In its most recent report, on August 4, 2026, APO reported EPS of $2.11. That result missed the analysts' figure by 2.31%. The market agreed: the stock fell 2.60% the following session.
Across the earnings record, APO beat estimates in 5 of the last 7 reports. Those beats have not always lifted the shares, though: the stock fell in the first session after 1 of the 5 beats.
APO is a premium to peers on its P/E of 39.89, which is 141.8% above the sector median, so any weaker results would face a tougher standard. A typical daily move in the price is 1.45%, measured as the 30-day standard deviation of daily returns, and its beta against the S&P 500 is 1.58. The trend is a headwind for holders until the price climbs back above its moving averages. The price is 27.14% below the 52-week high of $153.29.
APO against the Financial Services sector
How APO compares with the median Financial Services stock CleaRank tracks.
Price to earnings vs sector: APO trades at a significant premium to sector peers (+142%), suggesting market expectations for superior growth or market position.
Return vs XLF: Since May 9, 2025, APO has lost 15.7% against a gain of 12.4% for XLF.
Performance against XLF
APO and the Financial Services sector fund over the same days.
Revenue and earnings
How much APO sells, and how much of it becomes profit.
Revenue growth: Revenue grew 22.7% in FY2025 to $32.0B, from $26.1B a year earlier.
Profit margin: The net margin was 16.9% in FY2025, down from 24.4% the year before.
Profitable: APO earned $5.4B in FY2025.
Earnings reality check
Did APO beat what analysts expected, and how did the stock react?
Earnings record: APO beat the analyst estimate in 5 of the last 7 quarters.
Market reaction: The stock fell in the first session after 1 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 4, 2026after close | $2.16 | $2.11 | -2.31% | -2.60% | +5.32% |
| May 6, 2026after close | $1.88 | $1.94 | +3.19% | -1.34% | +1.60% |
| Nov 4, 2025after close | $1.90 | $2.17 | +14.21% | +2.48% | +1.82% |
| Aug 5, 2025after close | $1.84 | $1.92 | +4.35% | +0.23% | -0.65% |
| May 2, 2025after close | $1.84 | $1.82 | -1.09% | -1.03% | -2.15% |
| Feb 4, 2025after close | $1.89 | $2.22 | +17.46% | +1.94% | -2.77% |
| Nov 5, 2024after close | $1.72 | $1.85 | +7.56% | +9.65% | +9.70% |
As of October 22, 2026, APO has beaten the analyst EPS estimate in 5 of its last 7 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on August 4, 2026, came in 2.31% below the estimate and the stock moved -2.60% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 33.1, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 33.1 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of APO
The score, the reasoning behind it, and what could move the price next.
Apollo Global Management Inc. (APO) is trending down. The stock is at $111.69, which leaves it 10.84% below its 50-day average of $125.27 and 10.28% below its 200-day average of $124.49. Within its 52-week range, the price sits near the bottom: it is 12.18% above the low of $99.56 and 27.14% below the high of $153.29. The 50-day average is 0.63% above the 200-day average, so the longer averages have not yet adjusted to the weaker price.
The 14-day RSI of 33.1 is in the bearish zone, above the oversold line, and the MACD line is negative. The record is negative across every period shown: the price fell 6.17% over the past three months, fell 13.46% over the past six months and fell 11.34% over the past year.
New analyst coverage ›
Wells Fargo started coverage at Equal-Weight on October 2, 2026.
Source: Analyst action, Wells Fargo, October 2, 2026Rating reaffirmed ›
Piper Sandler kept its Overweight rating on October 19, 2026.
Source: Analyst action, Piper Sandler, October 19, 2026
Earnings miss ›
The August 4, 2026 report missed the EPS estimate by 2.31%, and the share price fell 2.60% in the first session after it.
Source: Earnings report, August 4, 2026
- Keep an eye on the two closest levels: the 20-day EMA at $116.09 sits above the price, and the 52-week low at $99.56 sits below it.
- The 14-day RSI reads 33.1, in the bearish zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- The share price slid 2.60% in the first session after the August 4, 2026 report. Over the last 7 reports, APO has beaten estimates in 5 of them.
APO sits below its 50-day and 200-day moving averages ($125.27 and $124.49), and that is why the trend reads down. A recovery back above the 200-day would be the first sign of repair. The nearest level above the price is the 20-day EMA at $116.09.
The next level below the price is the 52-week low of $99.56. With the RSI in the bearish zone, momentum still leans toward lower prices.
Technical indicators
Momentum and trend for APO, from its daily closes.
As of October 22, 2026, with APO at $111.69, its 14-day RSI is 33.1 (showing bearish momentum without being oversold), its 50-day simple moving average is $125.27 and its 200-day is $124.49.
Calculated by CleaRank on daily closes as of October 22, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What APO moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 22, 2026, APO's 1-year correlation of daily returns is +0.64 with S&P 500 (SPY), +0.56 with Nasdaq 100 (QQQ), +0.26 with Bitcoin (BTC) and +0.03 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
16 of 22 analysts rate it a buy or strong buy, 6 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $149.00 is 33.4% above the price.More buy ratings than three months ago ›
16 of 22 rate it a buy now, against 15 of 21 three months ago.
APO Wall Street View
12-month price targets
The price, $111.69, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 19, 2026 | Piper Sandler | Maintains | Overweight |
| Oct 13, 2026 | UBS | Maintains | Buy |
| Oct 12, 2026 | TD Cowen | Maintains | Buy |
| Oct 2, 2026 | Wells Fargo | Initiates | Equal-Weight |
| Sep 2, 2026 | JP Morgan | Maintains | Overweight |
| Aug 5, 2026 | UBS | Maintains | Buy |
As of October 22, 2026, 22 Wall Street analysts cover APO: 16 rate it a buy or strong buy, 6 a hold and 0 a sell or strong sell. Their 12-month price targets range from $127.00 to $173.00, with a median of $149.00, 33.4% above the price of $111.69.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
APO trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from APO's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much APO tends to move, against the market and on its own.
The long record
APO's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.45% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 41.4%, from January 2020 to March 2020, regained by June 2020.Most 1-year holds ended higher ›
78% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $90,809, against $42,099 in the S&P 500 (SPY).
APO Drawdowns & Recovery
As of October 22, 2026, APO's worst peak-to-trough fall over the last 10 years with dividends reinvested was -41.4% (January 2020 to March 2020); it regained that peak by June 2020, 3 months after the low, and 78% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into APO in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: APO beat the S&P 500 over this period: $90,809 against $42,099.
A $10,000 investment in APO in October 2016 would be worth about $90,809 today with dividends reinvested, compared with about $42,099 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to APO, and which have not.
Strongest month, November: an average of +7.33%, up in 7 of 10 years.
Weakest month, March: an average of -4.67%, up in 3 of 10 years.
This month, October: has averaged +2.25%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, APO's strongest calendar month has been November (average +7.33%, up in 7 of 10 years) and its weakest March (average -4.67%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in APO, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in APO today could grow to about $26,560 by 2036 in the base case, with a 90th-percentile outcome near $124,559 and a 10th-percentile outcome around $5,663. The simulation models price only; at today's 1.92% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
APO Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $165 for APO by 2030 in the base case, from $112 today (1.5x over 4 years). The 10th-percentile path ends near $62.12. These are outcomes of a Monte Carlo simulation run on APO's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $75.54 | $123 | $201 | |
| 2028 | $68.03 | $136 | $271 | |
| 2029 | $64.22 | $150 | $349 | |
| 2030 | $62.12 | $165 | $439 | |
| 2031 | $61.03 | $182 | $543 |
Method: a lognormal simulation of APO's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
APO insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $78K on the open market and sold $135.8M.
As of October 22, 2026, APO insiders reported 9 open-market sales worth $135.8M and 1 open-market purchase worth $78K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 10, 2026 | James Richard Belardi
Officer and Director
|
Grant | 38.6K | - |
| Aug 14, 2026 | Martin B Kelly
Chief Financial Officer
|
Sell | 3.0K | $422.5K |
| Aug 14, 2026 | Martin B Kelly
Chief Financial Officer
|
Grant | 1.5K | - |
| Jul 1, 2026 | Marc A. J.d. Beilinson
Director
|
Grant | 1.6K | - |
| Jul 1, 2026 | Jessica M Bibliowicz
Director
|
Grant | 1.6K | - |
| Jul 1, 2026 | Gary D Cohn
Director
|
Grant | 2.0K | - |
| Jul 1, 2026 | Kerry Murphy Healey
Director
|
Grant | 1.6K | - |
| Jul 1, 2026 | Pamela J Joyner
Director
|
Grant | 1.6K | - |
| Jul 1, 2026 | Brian Leach
Director
|
Grant | 1.6K | - |
| Jul 1, 2026 | Mitra O'Neill
Director
|
Grant | 1.6K | - |
| Jul 1, 2026 | Lynn C Swann
Director
|
Grant | 1.6K | - |
| Jul 1, 2026 | Patrick Toomey
Director
|
Grant | 1.6K | - |
| Jun 9, 2026 | Martin B Kelly
Chief Financial Officer
|
Grant | 1.3K | - |
| May 27, 2026 | John P. Zito
Officer
|
Sell | 48.6K | $6.4M |
| May 27, 2026 | Scott M Kleinman
Officer and Director
|
Grant | 13.4K | - |
| May 15, 2026 | Martin B Kelly
Chief Financial Officer
|
Grant | 570 | - |
| May 15, 2026 | Scott M Kleinman
Officer and Director
|
Grant | 3.2K | $415.0K |
| May 14, 2026 | Martin B Kelly
Chief Financial Officer
|
Sell | 7.0K | $942.5K |
| May 8, 2026 | Marc J Rowan
Chief Executive Officer
|
Grant | 140.0K | - |
| May 7, 2026 | Jessica M Bibliowicz
Director
|
Grant | 1.6K | - |
| May 7, 2026 | Gary D Cohn
Director
|
Grant | 3.3K | - |
| May 7, 2026 | Brian Leach
Director
|
Grant | 2.0K | - |
| May 7, 2026 | Mitra O'Neill
Director
|
Grant | 1.8K | - |
| Feb 17, 2026 | Scott M Kleinman
President
|
Grant | 2.0K | $264.7K |
| Feb 13, 2026 | James Richard Belardi
Officer and Director
|
Option | 147.8K | $4.4M |
| Feb 10, 2026 | James Richard Belardi
Officer and Director
|
Grant | 41.9K | - |
| Feb 10, 2026 | Whitney A Chatterjee
Officer
|
Grant | 96.0K | - |
| Feb 10, 2026 | Martin B Kelly
Chief Financial Officer
|
Grant | 116.1K | - |
| Feb 10, 2026 | Kristiane Elaine Kinahan
Officer
|
Grant | 10.9K | - |
| Feb 10, 2026 | Grant A Kvalheim
Officer
|
Grant | 19.0K | - |
| Feb 10, 2026 | James C Zelter
President
|
Grant | 29.3K | - |
| Feb 10, 2026 | John P. Zito
Officer
|
Grant | 167.3K | - |
| Dec 11, 2025 | James Richard Belardi
Officer and Director
|
Grant | 33.3K | - |
| Dec 10, 2025 | Whitney A Chatterjee
Officer
|
Sell | 8.5K | $1.2M |
| Dec 3, 2025 | Martin B Kelly
Chief Financial Officer
|
Grant | 1.0K | - |
| Dec 2, 2025 | James Richard Belardi
Officer and Director
|
Grant | 1.5K | - |
| Dec 1, 2025 | Martin B Kelly
Chief Financial Officer
|
Sell | 6.0K | $788.4K |
| Nov 13, 2025 | Scott M Kleinman
President
|
Grant | 10.1K | $1.3M |
| Nov 5, 2025 | Scott M Kleinman
Officer and Director
|
Grant | 26.3K | - |
| Oct 22, 2025 | Leon D Black
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 119.8K | - |
| Sep 11, 2025 | Marc J Rowan
Chief Executive Officer
|
Grant | 134.0K | - |
| Sep 4, 2025 | Leon D Black
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 915.0K | $122.6M |
| Aug 14, 2025 | Scott M Kleinman
President
|
Grant | 9.3K | $1.3M |
| Aug 12, 2025 | Martin B Kelly
Chief Financial Officer
|
Sell | 15.5K | $2.2M |
| Aug 12, 2025 | Martin B Kelly
Chief Financial Officer
|
Grant | 795 | - |
| Aug 6, 2025 | Whitney A Chatterjee
Officer
|
Sell | 4.5K | $657.1K |
| Jul 18, 2025 | Leon D Black
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 442.0K | - |
| Jul 15, 2025 | Leon D Black
Beneficial Owner of more than 10% of a Class of Security
|
Grant | 59.0K | - |
| Jul 1, 2025 | Marc A. J.d. Beilinson
Director
|
Grant | 1.4K | - |
| Jul 1, 2025 | Jessica M Bibliowicz
Director
|
Grant | 1.4K | - |
| Jul 1, 2025 | Gary D Cohn
Director
|
Grant | 1.8K | - |
| Jul 1, 2025 | Kerry Murphy Healey
Director
|
Grant | 1.4K | - |
| Jul 1, 2025 | Pamela J Joyner
Director
|
Grant | 1.4K | - |
| Jul 1, 2025 | Brian Leach
Director
|
Grant | 1.4K | - |
| Jul 1, 2025 | Mitra O'Neill
Director
|
Grant | 1.4K | - |
| Jul 1, 2025 | Pauline D E Richards
Director
|
Grant | 1.4K | - |
| Jul 1, 2025 | David E Simon
Director
|
Grant | 1.4K | - |
| Jul 1, 2025 | Lynn C Swann
Director
|
Grant | 1.4K | - |
| May 28, 2025 | Martin B Kelly
Chief Financial Officer
|
Grant | 25.0K | - |
| May 14, 2025 | Scott M Kleinman
Officer and Director
|
Grant | 4.0K | $539.5K |
| May 12, 2025 | Pauline D E Richards
Director
|
Buy | 550 | $78.1K |
| May 6, 2025 | Martin B Kelly
Chief Financial Officer
|
Sell | 4.0K | $530.3K |
| May 6, 2025 | Martin B Kelly
Chief Financial Officer
|
Grant | 230 | - |
| May 5, 2025 | Jessica M Bibliowicz
Director
|
Grant | 1.5K | - |
| May 5, 2025 | Alvin Bernard Krongard
Director
|
Grant | 1.4K | - |
| May 5, 2025 | Mitra O'Neill
Director
|
Grant | 1.8K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 22, 2026.